{"entity":{"type":"insider","cik":"0001289783","url":"/insider/0001289783","json_url":"/insider/0001289783.json","name":"Cavalier David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":64,"n_filings":12,"first":"2008-09-17","last":"2019-04-29","span_basis":"filed_date"},"name_variants":[{"name":"Cavalier David","source":"filing","n_filings":12,"first_seen":"2008-09-17","last_seen":"2019-04-29"}],"transactions":[{"id":8660083,"accession":"0001513162-19-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001513162-19-000115","line_url":"/filing/0001513162-19-000115#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"Anixa Biosciences Inc","issuer_ticker":"ANIX","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.21,"price_display":"4.21","price_state":"stated","total_value":8420.0,"total_display":"8,420.00","total_whole":"8,420","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-29","filed_date":"2019-04-29","scope":"insider"},{"id":7537433,"accession":"0001144204-10-044309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-10-044309","line_url":"/filing/0001144204-10-044309#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500000.0,"shares_display":"2,500,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":34415876.0,"shares_owned_after_display":"34,415,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-11","filed_date":"2010-08-16","scope":"insider"},{"id":9274474,"accession":"0001223692-09-000042","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-09-000042","line_url":"/filing/0001223692-09-000042#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.475,"price_display":"0.48","price_state":"stated","total_value":4750.0,"total_display":"4,750.00","total_whole":"4,750","shares_owned_after":26023019.0,"shares_owned_after_display":"26,023,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-28","filed_date":"2009-12-29","scope":"insider"},{"id":9274475,"accession":"0001223692-09-000042","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001223692-09-000042","line_url":"/filing/0001223692-09-000042#line-5","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":4300.0,"total_display":"4,300.00","total_whole":"4,300","shares_owned_after":25298733.0,"shares_owned_after_display":"25,298,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-29","scope":"insider"},{"id":9274476,"accession":"0001223692-09-000042","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001223692-09-000042","line_url":"/filing/0001223692-09-000042#line-4","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.415,"price_display":"0.42","price_state":"stated","total_value":4150.0,"total_display":"4,150.00","total_whole":"4,150","shares_owned_after":25288733.0,"shares_owned_after_display":"25,288,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-22","filed_date":"2009-12-29","scope":"insider"},{"id":9274477,"accession":"0001223692-09-000042","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001223692-09-000042","line_url":"/filing/0001223692-09-000042#line-3","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4338,"price_display":"0.43","price_state":"stated","total_value":4338.0,"total_display":"4,338.00","total_whole":"4,338","shares_owned_after":25278733.0,"shares_owned_after_display":"25,278,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-21","filed_date":"2009-12-29","scope":"insider"},{"id":9274478,"accession":"0001223692-09-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000042","line_url":"/filing/0001223692-09-000042#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.3825,"price_display":"0.38","price_state":"stated","total_value":3825.0,"total_display":"3,825.00","total_whole":"3,825","shares_owned_after":25268733.0,"shares_owned_after_display":"25,268,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-18","filed_date":"2009-12-29","scope":"insider"},{"id":9274473,"accession":"0001223692-09-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000042","line_url":"/filing/0001223692-09-000042#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.3538,"price_display":"0.35","price_state":"stated","total_value":7076.0,"total_display":"7,076.00","total_whole":"7,076","shares_owned_after":25258733.0,"shares_owned_after_display":"25,258,733","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-29","scope":"insider"},{"id":5807045,"accession":"0001223692-09-000033","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-09-000033","line_url":"/filing/0001223692-09-000033#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5892857.0,"shares_display":"5,892,857","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1649999.96,"total_display":"1,649,999.96","total_whole":"1,650,000","shares_owned_after":22344597.0,"shares_owned_after_display":"22,344,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-10-06","filed_date":"2009-10-21","scope":"insider"},{"id":5807037,"accession":"0001223692-09-000033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000033","line_url":"/filing/0001223692-09-000033#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","total_whole":"7,800","shares_owned_after":16356203.0,"shares_owned_after_display":"16,356,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-22","filed_date":"2009-10-21","scope":"insider"},{"id":5807034,"accession":"0001223692-09-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000033","line_url":"/filing/0001223692-09-000033#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.3925,"price_display":"0.39","price_state":"stated","total_value":7850.0,"total_display":"7,850.00","total_whole":"7,850","shares_owned_after":16336203.0,"shares_owned_after_display":"16,336,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-02","filed_date":"2009-10-21","scope":"insider"},{"id":9274457,"accession":"0001223692-09-000014","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-18","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5357143.0,"shares_display":"5,357,143","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1500000.04,"total_display":"1,500,000.04","total_whole":"1,500,000","shares_owned_after":16316203.0,"shares_owned_after_display":"16,316,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-04-20","scope":"insider"},{"id":5689074,"accession":"0001223692-09-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000012","line_url":"/filing/0001223692-09-000012#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5357143.0,"shares_display":"5,357,143","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1500000.04,"total_display":"1,500,000.04","total_whole":"1,500,000","shares_owned_after":16186203.0,"shares_owned_after_display":"16,186,203","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-04-02","scope":"insider"},{"id":9274456,"accession":"0001223692-09-000014","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-17","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.4175,"price_display":"0.42","price_state":"stated","total_value":8350.0,"total_display":"8,350.00","total_whole":"8,350","shares_owned_after":10959060.0,"shares_owned_after_display":"10,959,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-24","filed_date":"2009-04-20","scope":"insider"},{"id":9274451,"accession":"0001223692-09-000014","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-16","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":10939060.0,"shares_owned_after_display":"10,939,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-11","filed_date":"2009-04-20","scope":"insider"},{"id":9274450,"accession":"0001223692-09-000014","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-15","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.4338,"price_display":"0.43","price_state":"stated","total_value":17352.0,"total_display":"17,352.00","total_whole":"17,352","shares_owned_after":10919060.0,"shares_owned_after_display":"10,919,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-10","filed_date":"2009-04-20","scope":"insider"},{"id":9274449,"accession":"0001223692-09-000014","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-14","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79838.0,"shares_display":"79,838","price_per_share":0.348,"price_display":"0.35","price_state":"stated","total_value":27783.624,"total_display":"27,783.62","total_whole":"27,784","shares_owned_after":10879060.0,"shares_owned_after_display":"10,879,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-31","filed_date":"2009-04-20","scope":"insider"},{"id":5689073,"accession":"0001223692-09-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000012","line_url":"/filing/0001223692-09-000012#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79838.0,"shares_display":"79,838","price_per_share":0.348,"price_display":"0.35","price_state":"stated","total_value":27783.624,"total_display":"27,783.62","total_whole":"27,784","shares_owned_after":10829060.0,"shares_owned_after_display":"10,829,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-31","filed_date":"2009-04-02","scope":"insider"},{"id":9274466,"accession":"0001223692-09-000014","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-13","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":1750.0,"total_display":"1,750.00","total_whole":"1,750","shares_owned_after":10799222.0,"shares_owned_after_display":"10,799,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-31","filed_date":"2009-04-20","scope":"insider"},{"id":9274465,"accession":"0001223692-09-000014","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-12","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","total_whole":"3,200","shares_owned_after":10794222.0,"shares_owned_after_display":"10,794,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-30","filed_date":"2009-04-20","scope":"insider"},{"id":3920491,"accession":"0001223692-08-000027","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-08-000027","line_url":"/filing/0001223692-08-000027#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","total_whole":"3,200","shares_owned_after":10749222.0,"shares_owned_after_display":"10,749,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-30","filed_date":"2008-12-31","scope":"insider"},{"id":9274464,"accession":"0001223692-09-000014","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-11","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1950.0,"total_display":"1,950.00","total_whole":"1,950","shares_owned_after":10784222.0,"shares_owned_after_display":"10,784,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-29","filed_date":"2009-04-20","scope":"insider"},{"id":9274463,"accession":"0001223692-09-000014","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-10","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7950.0,"shares_display":"7,950","price_per_share":0.3069,"price_display":"0.31","price_state":"stated","total_value":2439.855,"total_display":"2,439.86","total_whole":"2,440","shares_owned_after":10779222.0,"shares_owned_after_display":"10,779,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-26","filed_date":"2009-04-20","scope":"insider"},{"id":9274462,"accession":"0001223692-09-000014","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-9","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":1470.0,"total_display":"1,470.00","total_whole":"1,470","shares_owned_after":10771372.0,"shares_owned_after_display":"10,771,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-24","filed_date":"2009-04-20","scope":"insider"},{"id":9274461,"accession":"0001223692-09-000014","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-8","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":780.0,"total_display":"780.00","total_whole":"780","shares_owned_after":10766372.0,"shares_owned_after_display":"10,766,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-17","filed_date":"2009-04-20","scope":"insider"},{"id":9274460,"accession":"0001223692-09-000014","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-7","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.345,"price_display":"0.34","price_state":"stated","total_value":690.0,"total_display":"690.00","total_whole":"690","shares_owned_after":10764372.0,"shares_owned_after_display":"10,764,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-16","filed_date":"2009-04-20","scope":"insider"},{"id":9274459,"accession":"0001223692-09-000014","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-6","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.345,"price_display":"0.34","price_state":"stated","total_value":3450.0,"total_display":"3,450.00","total_whole":"3,450","shares_owned_after":10762372.0,"shares_owned_after_display":"10,762,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-10","filed_date":"2009-04-20","scope":"insider"},{"id":9274458,"accession":"0001223692-09-000014","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-5","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.3475,"price_display":"0.35","price_state":"stated","total_value":6950.0,"total_display":"6,950.00","total_whole":"6,950","shares_owned_after":10752372.0,"shares_owned_after_display":"10,752,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-28","filed_date":"2009-04-20","scope":"insider"},{"id":9274455,"accession":"0001223692-09-000014","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-4","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.3295,"price_display":"0.33","price_state":"stated","total_value":13180.0,"total_display":"13,180.00","total_whole":"13,180","shares_owned_after":10732372.0,"shares_owned_after_display":"10,732,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-21","filed_date":"2009-04-20","scope":"insider"},{"id":3456278,"accession":"0001223692-08-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-08-000018","line_url":"/filing/0001223692-08-000018#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.3295,"price_display":"0.33","price_state":"stated","total_value":13180.0,"total_display":"13,180.00","total_whole":"13,180","shares_owned_after":10717372.0,"shares_owned_after_display":"10,717,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-21","filed_date":"2008-12-03","scope":"insider"},{"id":9274454,"accession":"0001223692-09-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-3","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":10692372.0,"shares_owned_after_display":"10,692,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-14","filed_date":"2009-04-20","scope":"insider"},{"id":3948111,"accession":"0001223692-08-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-08-000014","line_url":"/filing/0001223692-08-000014#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":10677372.0,"shares_owned_after_display":"10,677,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-14","filed_date":"2008-10-17","scope":"insider"},{"id":9274453,"accession":"0001223692-09-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":6150.0,"total_display":"6,150.00","total_whole":"6,150","shares_owned_after":10677372.0,"shares_owned_after_display":"10,677,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-10","filed_date":"2009-04-20","scope":"insider"},{"id":9274452,"accession":"0001223692-09-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001223692-09-000014","line_url":"/filing/0001223692-09-000014#line-1","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.4133,"price_display":"0.41","price_state":"stated","total_value":6199.5,"total_display":"6,199.50","total_whole":"6,200","shares_owned_after":10662372.0,"shares_owned_after_display":"10,662,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-07","filed_date":"2009-04-20","scope":"insider"},{"id":3716310,"accession":"0001223692-08-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001223692-08-000009","line_url":"/filing/0001223692-08-000009#line-3","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.4333,"price_display":"0.43","price_state":"stated","total_value":6499.5,"total_display":"6,499.50","total_whole":"6,500","shares_owned_after":10647372.0,"shares_owned_after_display":"10,647,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-29","filed_date":"2008-10-01","scope":"insider"},{"id":2673297,"accession":"0001223692-08-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001223692-08-000007","line_url":"/filing/0001223692-08-000007#line-2","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":3900.0,"total_display":"3,900.00","total_whole":"3,900","shares_owned_after":10622372.0,"shares_owned_after_display":"10,622,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-18","filed_date":"2008-09-19","scope":"insider"},{"id":3176471,"accession":"0001223692-08-000005","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-29","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7020.0,"shares_display":"7,020","price_per_share":0.3631,"price_display":"0.36","price_state":"stated","total_value":2548.962,"total_display":"2,548.96","total_whole":"2,549","shares_owned_after":10601372.0,"shares_owned_after_display":"10,601,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-09-12","filed_date":"2008-09-17","scope":"insider"},{"id":3176463,"accession":"0001223692-08-000005","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-27","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.4117,"price_display":"0.41","price_state":"stated","total_value":2470.2,"total_display":"2,470.20","total_whole":"2,470","shares_owned_after":10592152.0,"shares_owned_after_display":"10,592,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-18","filed_date":"2008-09-17","scope":"insider"},{"id":3176458,"accession":"0001223692-08-000005","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-26","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.4033,"price_display":"0.40","price_state":"stated","total_value":2419.8,"total_display":"2,419.80","total_whole":"2,420","shares_owned_after":10586152.0,"shares_owned_after_display":"10,586,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-08","filed_date":"2008-09-17","scope":"insider"},{"id":3176455,"accession":"0001223692-08-000005","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-25","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":80.0,"total_display":"80.00","total_whole":"80","shares_owned_after":10580152.0,"shares_owned_after_display":"10,580,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-07","filed_date":"2008-09-17","scope":"insider"},{"id":3176449,"accession":"0001223692-08-000005","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20100.0,"shares_display":"20,100","price_per_share":0.35495373134328356,"price_display":"0.35","price_state":"stated","total_value":7134.57,"total_display":"7,134.57","total_whole":"7,135","shares_owned_after":10579952.0,"shares_owned_after_display":"10,579,952","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-04","filed_date":"2008-09-17","scope":"insider","n_lines":2},{"id":3176435,"accession":"0001223692-08-000005","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-22","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":9200.0,"total_display":"9,200.00","total_whole":"9,200","shares_owned_after":10559852.0,"shares_owned_after_display":"10,559,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-29","filed_date":"2008-09-17","scope":"insider"},{"id":3176431,"accession":"0001223692-08-000005","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-21","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.466,"price_display":"0.47","price_state":"stated","total_value":23300.0,"total_display":"23,300.00","total_whole":"23,300","shares_owned_after":10539852.0,"shares_owned_after_display":"10,539,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-15","filed_date":"2008-09-17","scope":"insider"},{"id":3176427,"accession":"0001223692-08-000005","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-20","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15100.0,"shares_display":"15,100","price_per_share":0.48,"price_display":"0.48","price_state":"stated","total_value":7248.0,"total_display":"7,248.00","total_whole":"7,248","shares_owned_after":10489852.0,"shares_owned_after_display":"10,489,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-03","filed_date":"2008-09-17","scope":"insider"},{"id":3176424,"accession":"0001223692-08-000005","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-19","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","total_whole":"1,900","shares_owned_after":10474752.0,"shares_owned_after_display":"10,474,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-31","filed_date":"2008-09-17","scope":"insider"},{"id":3176421,"accession":"0001223692-08-000005","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-18","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":3700.0,"total_display":"3,700.00","total_whole":"3,700","shares_owned_after":10469752.0,"shares_owned_after_display":"10,469,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-28","filed_date":"2008-09-17","scope":"insider"},{"id":3176416,"accession":"0001223692-08-000005","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-17","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.36,"price_display":"0.36","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":10459752.0,"shares_owned_after_display":"10,459,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-24","filed_date":"2008-09-17","scope":"insider"},{"id":3176412,"accession":"0001223692-08-000005","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-16","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":7600.0,"total_display":"7,600.00","total_whole":"7,600","shares_owned_after":10449752.0,"shares_owned_after_display":"10,449,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-20","filed_date":"2008-09-17","scope":"insider"},{"id":3176408,"accession":"0001223692-08-000005","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001223692-08-000005","line_url":"/filing/0001223692-08-000005#line-15","is_derivative":false,"issuer_cik":"0001261734","issuer_name":"AEOLUS PHARMACEUTICALS, INC.","issuer_ticker":"AOLS","issuer_name_source":null,"issuer_url":"/issuer/0001261734","owner_cik":"0001289783","owner_name":"Cavalier David","owner_display_name":"Cavalier David","owner_url":"/insider/0001289783","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":3800.0,"total_display":"3,800.00","total_whole":"3,800","shares_owned_after":10429752.0,"shares_owned_after_display":"10,429,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-19","filed_date":"2008-09-17","scope":"insider"}],"collapsed":true,"next_cursor":"2008-03-19|3176408","ledger_fault":false,"count":{"value":64,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":64,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":64},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000715446","name":"Anixa Biosciences Inc","url":"/issuer/0000715446","role":"Director","n_filings":1,"first_seen":"2019-04-29","last_seen":"2019-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001261734","name":"AEOLUS PHARMACEUTICALS, INC.","url":"/issuer/0001261734","role":"Director, Ten percent owner","n_filings":11,"first_seen":"2008-09-17","last_seen":"2010-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001289783","retrieved_at":"2026-08-22T08:51:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}